InsiderTrades.com logo

ENFN Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 36.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,352,145.21

Enfusion Insider Trading History Chart

This chart shows the insider buying and selling history at Enfusion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Enfusion Share Price & Price History

Current Price: $10.85
Price Change: ▲ Price Increase of +0.049 (0.45%)
As of 04/17/2025 05:24 PM ET

This chart shows the closing price history over time for ENFN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Enfusion (NYSE:ENFN)

81.05% of Enfusion stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENFN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$94Mbought$1.37MsoldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50M$0$50MTotal InflowsTotal Outflows
Enfusion logo
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
Read More on Enfusion

Today's Range

Now: $10.85
Low: $10.74
High: $10.87

50 Day Range

MA: $10.85
Low: $10.85
High: $10.85

52 Week Range

Now: $10.85
Low: $7.83
High: $11.80

Volume

2,461,878 shs

Average Volume

730,867 shs

Market Capitalization

$1.40 billion

P/E Ratio

271.29

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Enfusion?

Enfusion's top insider shareholders include:
  1. Oleg Movchan (CEO)
  2. Neal Pawar (COO)
  3. Bradley Herring (CFO)
  4. Bronwen Bastone (Insider)
  5. Dan Groman (CTO)
  6. Matthew Campobasso (General Counsel)
  7. Valeria Gutowski (CAO)
  8. Deirdre Somers (Director)
  9. Stephen Malherbe (Major Shareholder)
Learn More about top insider investors at Enfusion.